PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.\', \'Laboratory Science, Macha Research Trust, Choma, Zambia.\', \'Department of Immunology, Tropical Diseases Research Center, Ndola, Zambia.\', \'Ministry of the Health, Government of the Republic of Zambia, Lusaka, Zambia.\', \'Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.\', \'W Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1080/21645515.2021.1948784
?:hasPublicationType
?:journal
  • Human vaccines & immunotherapeutics
is ?:pmid of
?:pmid
?:pmid
  • 34227914
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • COVID-19 vaccine hesitancy in Zambia: a glimpse at the possible challenges ahead for COVID-19 vaccination rollout in sub-Saharan Africa.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all